Table S1. Dysregulated cytokines and specific autoimmune diseases included in the studyâs autoimmune definition. (DOCX 16 kb
Table S1. Prospective multicenter cohort studies (noninterventional) among patients with severe seps...
Supplementary tables. Table S1. Results of quality assessment of included studies using Newcastle-Ot...
Table S1. Characteristics of patients with sepsis included in the study. Results are shown for all p...
Table S6. Association between each autoimmune disease and 30-day mortality. (DOCX 14 kb
Table S3. Analysis of the impact of individual comorbidities on the autoimmune disease-30-day mortal...
Table S5. Survival analysis of the five most frequently reported autoimmune diseases. (DOCX 13 kb
Table S4. Impact of adjusting for potential confounders and SOFA score on the autoimmune disease-30-...
Table S2. Biologic and conventional DMARD medications included in the present study. (DOCX 13 kb
Table S7. Sensitivity analysis exploring the potential effect of diagnostic bias among other immunoc...
Characteristics of enzyme-linked immunosorbent assays for plasma proteins. Table S2. Patient charact...
Table S1. Intraclass correlation coefficients (ICCs) with 95% CI for the association between predict...
Table S1. Demographic characteristics of patients in both study phases. (DOCX 16 kb
Sepsis results from a dysregulated host response to an infection that is associated with an imbalanc...
Leukocyte counts in survivors and non-survivors for the first 7Â days following sepsis diagnosis. (P...
Table S1. Comparison of comorbidities between patients with infection and sepsis developing in the f...
Table S1. Prospective multicenter cohort studies (noninterventional) among patients with severe seps...
Supplementary tables. Table S1. Results of quality assessment of included studies using Newcastle-Ot...
Table S1. Characteristics of patients with sepsis included in the study. Results are shown for all p...
Table S6. Association between each autoimmune disease and 30-day mortality. (DOCX 14 kb
Table S3. Analysis of the impact of individual comorbidities on the autoimmune disease-30-day mortal...
Table S5. Survival analysis of the five most frequently reported autoimmune diseases. (DOCX 13 kb
Table S4. Impact of adjusting for potential confounders and SOFA score on the autoimmune disease-30-...
Table S2. Biologic and conventional DMARD medications included in the present study. (DOCX 13 kb
Table S7. Sensitivity analysis exploring the potential effect of diagnostic bias among other immunoc...
Characteristics of enzyme-linked immunosorbent assays for plasma proteins. Table S2. Patient charact...
Table S1. Intraclass correlation coefficients (ICCs) with 95% CI for the association between predict...
Table S1. Demographic characteristics of patients in both study phases. (DOCX 16 kb
Sepsis results from a dysregulated host response to an infection that is associated with an imbalanc...
Leukocyte counts in survivors and non-survivors for the first 7Â days following sepsis diagnosis. (P...
Table S1. Comparison of comorbidities between patients with infection and sepsis developing in the f...
Table S1. Prospective multicenter cohort studies (noninterventional) among patients with severe seps...
Supplementary tables. Table S1. Results of quality assessment of included studies using Newcastle-Ot...
Table S1. Characteristics of patients with sepsis included in the study. Results are shown for all p...
DOI
Add to ORKG